乳がんスクリーニング市場：技術、製品、エンドユーザー別-2023-2030年の世界予測

乳がんスクリーニング市場は、予測期間中のCAGRは6.61%で、2022年の47億3,000万米ドルから2030年には79億米ドルに達すると予測されています。

乳がんスクリーニングの世界市場

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは乳がんスクリーニング市場の評価に不可欠なツールです。事業戦略や製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.乳がんスクリーニング市場の市場規模および予測は？

2.乳がんスクリーニング市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.乳がんスクリーニング市場における競争戦略の窓とは？

4.乳がんスクリーニング市場の最新技術動向と規制の枠組みは？

5.乳がんスクリーニング市場における主要ベンダーの市場シェアは？

6.乳がんスクリーニング市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界的に女性のがん症例が増加
    • 病気への意識を高めるための政府の健康キャンペーン
    • スクリーニングとモニタリングにMRI技術を大幅に採用。
  • 抑制要因
    • 乳がんスクリーニングデバイスのリコール
  • 機会
    • AIを活用したがん検診用3Dマンモグラム検査の登場
    • 先進的な免疫療法の導入
  • 課題
    • 誤った結果が生じる潜在的なリスク
• 市場セグメンテーション分析
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 乳がんスクリーニング市場：技術別

• イオン化乳房画像化技術
  • 3D乳房トモシンセシス
  • アナログマンモグラフィー
  • コーンビームコンピュータ断層撮影法（CBCT）
  • 造影マンモグラフィー（CEM）
  • 全視野デジタルマンモグラフィー（FFDM）
  • 乳房分子イメージング/乳房特異的ガンマイメージング（MBI/BSGI）
  • 陽電子放射マンモグラフィー（PEM）
  • 陽電子放出断層撮影法およびコンピュータ断層撮影法（PET-CT）
• 非電離乳房画像技術
  • 自動全乳房超音波検査（AWBU）
  • 乳房MRI
  • 乳房サーモグラフィー
  • 乳房超音波検査
  • 電気インピーダンス断層撮影法
  • 光学イメージング

第7章 乳がんスクリーニング市場：製品別

• アクセサリー
• 乳房画像診断システム
• ソフトウェアとサービス

第8章 乳がんスクリーニング市場：エンドユーザー別

• ブレストケアセンター
• 画像診断センター
• 病院とクリニック

第9章 南北アメリカの乳がんスクリーニング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の乳がんスクリーニング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの乳がんスクリーニング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第13章 競争力のあるポートフォリオ

• 主要企業プロファイル
  • AstraZeneca plc
  • Bayer AG
  • Becton, Dickinson and Company
  • Carestream Health, Inc.
  • Danaher Corporation
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • GlaxoSmithKline plc
  • Hologic, Inc.
  • Koning Health
  • Koninklijke Philips N.V.
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • NIRAMAI Health Analytix Private Limited
  • Novartis AG
  • Oncocyte Corporation
  • OncoStem Diagnostics Pvt. Ltd
  • Pfizer Inc.
  • Prelude Corporation
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • Syantra Inc.
  • Vayyar Imaging, Ltd.
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. BREAST CANCER SCREENING MARKET RESEARCH PROCESS
• FIGURE 2. BREAST CANCER SCREENING MARKET SIZE, 2022 VS 2030
• FIGURE 3. BREAST CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 5. BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 6. BREAST CANCER SCREENING MARKET DYNAMICS
• FIGURE 7. BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 8. BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 10. BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 12. BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 14. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
• FIGURE 16. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 21. BREAST CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 22. BREAST CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BREAST CANCER SCREENING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BREAST CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 6. BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 8. BREAST CANCER SCREENING MARKET SIZE, BY 3D BREAST TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. BREAST CANCER SCREENING MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. BREAST CANCER SCREENING MARKET SIZE, BY CONE-BEAM COMPUTED TOMOGRAPHY (CBCT), BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BREAST CANCER SCREENING MARKET SIZE, BY CONTRAST-ENHANCED MAMMOGRAPHY (CEM), BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. BREAST CANCER SCREENING MARKET SIZE, BY FULL-FIELD DIGITAL MAMMOGRAPHY (FFDM), BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING/BREAST SPECIFIC GAMMA IMAGING (MBI/BSGI), BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. BREAST CANCER SCREENING MARKET SIZE, BY POSITRON EMISSION MAMMOGRAPHY (PEM), BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. BREAST CANCER SCREENING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT), BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 18. BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU), BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. BREAST CANCER SCREENING MARKET SIZE, BY BREAST MRI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. BREAST CANCER SCREENING MARKET SIZE, BY BREAST THERMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. BREAST CANCER SCREENING MARKET SIZE, BY BREAST ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. BREAST CANCER SCREENING MARKET SIZE, BY ELECTRIC IMPEDANCE TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. BREAST CANCER SCREENING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. BREAST CANCER SCREENING MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. BREAST CANCER SCREENING MARKET SIZE, BY BREAST IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. BREAST CANCER SCREENING MARKET SIZE, BY BREAST CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. CANADA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. CANADA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 50. CANADA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 51. CANADA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. CANADA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. CHINA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. CHINA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 77. CHINA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 78. CHINA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. CHINA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. INDIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. INDIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 82. INDIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 83. INDIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. INDIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. ITALY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. ITALY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 168. ITALY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 169. ITALY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. ITALY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. POLAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. POLAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 188. POLAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 189. POLAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. POLAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. QATAR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. QATAR BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 193. QATAR BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 194. QATAR BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 195. QATAR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 241. BREAST CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 242. BREAST CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 243. BREAST CANCER SCREENING MARKET LICENSE & PRICING

The Breast Cancer Screening Market is projected to reach USD 7.90 billion by 2030 from USD 4.73 billion in 2022, at a CAGR of 6.61% during the forecast period.

Global Breast Cancer Screening Market

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Breast Cancer Screening Market.

Based on Technology, market is studied across Ionizing Breast Imaging Technologies and Non-ionizing Breast Imaging Technologies. The Ionizing Breast Imaging Technologies is further studied across 3D Breast Tomosynthesis, Analog Mammography, Cone-Beam Computed Tomography (CBCT), Contrast-Enhanced Mammography (CEM), Full-Field Digital Mammography (FFDM), Molecular Breast Imaging/Breast Specific Gamma Imaging (MBI/BSGI), Positron Emission Mammography (PEM), and Positron Emission Tomography and Computed Tomography (PET-CT). The Non-ionizing Breast Imaging Technologies is further studied across Automated Whole-Breast Ultrasound (AWBU), Breast MRI, Breast Thermography, Breast Ultrasound, Electric Impedance Tomography, and Optical Imaging. The Non-ionizing Breast Imaging Technologies is projected to witness significant market share during forecast period.

Based on Product, market is studied across Accessories, Breast Imaging Systems, and Software & Services. The Breast Imaging Systems is projected to witness significant market share during forecast period.

Based on End User, market is studied across Breast Care Centers, Diagnostic Imaging Centers, and Hospitals & Clinics. The Diagnostic Imaging Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Breast Cancer Screening Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Breast Cancer Screening Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Breast Cancer Screening Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca plc, Bayer AG, Becton, Dickinson and Company, Carestream Health, Inc., Danaher Corporation, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., GlaxoSmithKline plc, Hologic, Inc., Koning Health, Koninklijke Philips N.V., Myriad Genetics, Inc., NanoString Technologies, Inc., NIRAMAI Health Analytix Private Limited, Novartis AG, Oncocyte Corporation, OncoStem Diagnostics Pvt. Ltd, Pfizer Inc., Prelude Corporation, Quest Diagnostics Incorporated, Siemens Healthineers AG, Syantra Inc., and Vayyar Imaging, Ltd..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Breast Cancer Screening Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Breast Cancer Screening Market?

3. What is the competitive strategic window for identifying opportunities in the Breast Cancer Screening Market?

4. What are the latest technology trends and regulatory frameworks in the Breast Cancer Screening Market?

5. What is the market share of the leading vendors in the Breast Cancer Screening Market?

6. Which modes and strategic moves are suitable for entering the Breast Cancer Screening Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Breast Cancer Screening Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of cancer in women globally
    • 5.1.1.2. Government health campaign to raise disease awareness
    • 5.1.1.3. Significant adoption of MRI techniques for screening and monitoring.
  • 5.1.2. Restraints
    • 5.1.2.1. Breast cancer screening device recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of AI-supported 3D mammogram screening for cancer screening
    • 5.1.3.2. Adoption of advanced Immunotherapy
  • 5.1.4. Challenges
    • 5.1.4.1. Potential risk of false results
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Breast Cancer Screening Market, by Technology

• 6.1. Introduction
• 6.2. Ionizing Breast Imaging Technologies
  • 6.3.1. 3D Breast Tomosynthesis
  • 6.3.2. Analog Mammography
  • 6.3.3. Cone-Beam Computed Tomography (CBCT)
  • 6.3.4. Contrast-Enhanced Mammography (CEM)
  • 6.3.5. Full-Field Digital Mammography (FFDM)
  • 6.3.6. Molecular Breast Imaging/Breast Specific Gamma Imaging (MBI/BSGI)
  • 6.3.7. Positron Emission Mammography (PEM)
  • 6.3.8. Positron Emission Tomography and Computed Tomography (PET-CT)
• 6.3. Non-ionizing Breast Imaging Technologies
  • 6.4.1. Automated Whole-Breast Ultrasound (AWBU)
  • 6.4.2. Breast MRI
  • 6.4.3. Breast Thermography
  • 6.4.4. Breast Ultrasound
  • 6.4.5. Electric Impedance Tomography
  • 6.4.6. Optical Imaging

7. Breast Cancer Screening Market, by Product

• 7.1. Introduction
• 7.2. Accessories
• 7.3. Breast Imaging Systems
• 7.4. Software & Services

8. Breast Cancer Screening Market, by End User

• 8.1. Introduction
• 8.2. Breast Care Centers
• 8.3. Diagnostic Imaging Centers
• 8.4. Hospitals & Clinics

9. Americas Breast Cancer Screening Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Breast Cancer Screening Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Breast Cancer Screening Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. AstraZeneca plc
  • 13.1.2. Bayer AG
  • 13.1.3. Becton, Dickinson and Company
  • 13.1.4. Carestream Health, Inc.
  • 13.1.5. Danaher Corporation
  • 13.1.6. Exact Sciences Corporation
  • 13.1.7. F. Hoffmann-La Roche Ltd
  • 13.1.8. Fujifilm Holdings Corporation
  • 13.1.9. GE HealthCare Technologies Inc.
  • 13.1.10. GlaxoSmithKline plc
  • 13.1.11. Hologic, Inc.
  • 13.1.12. Koning Health
  • 13.1.13. Koninklijke Philips N.V.
  • 13.1.14. Myriad Genetics, Inc.
  • 13.1.15. NanoString Technologies, Inc.
  • 13.1.16. NIRAMAI Health Analytix Private Limited
  • 13.1.17. Novartis AG
  • 13.1.18. Oncocyte Corporation
  • 13.1.19. OncoStem Diagnostics Pvt. Ltd
  • 13.1.20. Pfizer Inc.
  • 13.1.21. Prelude Corporation
  • 13.1.22. Quest Diagnostics Incorporated
  • 13.1.23. Siemens Healthineers AG
  • 13.1.24. Syantra Inc.
  • 13.1.25. Vayyar Imaging, Ltd.
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing